SightfileU.S. market data from official filings

HCA HEALTHCARE INC (HCA)

Name: HCA HEALTHCARE INC (HCA) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000860730 · EDGAR filings · Updated 2026-07-28

HCA HEALTHCARE INC (HCA) has reported institutional ownership of 60.3%, with 1,403 institutional managers holding positions valued at $61.7B per the latest 13F reporting period. The company has 42 bond series in the registry.

Institutional ownership

60.3%

Institutional managers

1,403

Reported 13F value

$61.7B

Insider activity

91 trans.

−$38.5M net selling

Filings this week (2)

2026-07-28 — Quarterly report (10-Q) filed
2026-07-24 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

2026-07-14 — Current report (8-K) filed
2026-06-18 — Current report (8-K) filed
2026-05-11 — Insider transaction reported (Form 4)
2026-04-30 — Insider transaction reported (Form 4)
2026-04-30 — Insider transaction reported (Form 4)
2026-04-30 — Insider transaction reported (Form 4)
2026-04-30 — Insider transaction reported (Form 4)
2026-04-30 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, HCA HEALTHCARE INC has 1,403 institutional holders and institutional ownership of 60.3%.

#	Institution	Reported value	% of tracked total
1	BlackRock, Inc.	$6.32B	10.3%
2	VANGUARD CAPITAL MANAGEMENT LLC	$4.82B	7.8%
3	Sanders Capital, LLC	$4.24B	6.9%
4	STATE STREET CORP	$3.57B	5.8%
5	FMR LLC	$2.08B	3.4%
6	WELLINGTON MANAGEMENT GROUP LLP	$1.85B	3.0%
7	GEODE CAPITAL MANAGEMENT, LLC	$1.74B	2.8%
8	First Eagle Investment Management, LLC	$1.54B	2.5%
9	Capital International Investors	$1.44B	2.3%
10	VANGUARD PORTFOLIO MANAGEMENT LLC	$1.31B	2.1%

Full holder history and quarter-over-quarter changes are available inside the app.

Insider activity

Insiders reported 91 transactions (0 buys, 15 sells) across 21 reporting insiders, with a net reported value of −$38.5M.

Quarterly net insider value, as reported in Form 4 filings.

Debt profile

42 active bond series in the registry, coupons ranging 2.00%–8.00%, maturities through 2095, built from the company's own prospectus filings.

Debt maturity schedule

Principal coming due by year for HCA HEALTHCARE INC, from the company's own SEC prospectus filings (424B) tracked by Sightfile.

Year	Bond series maturing	Known principal due
2026	3	$5.50B
2027	4	$1.35B
2028	3	$2.50B
2029	3	$1.50B
2030	3	$2.70B
2031	3	$1.00B
2032	3	—
2033	3	$1.50B
2034	2	$2.05B
2035	2	—
2036	2	$100.0M
2039	1	—

Coupons, seniority and prospectus links for each series are available inside the app.

Fails-to-deliver

The SEC's fails-to-deliver file for 2026-06-29 reports 2 failed-to-deliver shares ($461.8K) for HCA — an official data point published by the SEC, shown as reported.

Related companies

MEDTRONIC PLC (MDT) · BOSTON SCIENTIFIC CORP (BSX) · REGENERON PHARMACEUTICAL (REGN) · 3M CO (MMM) · ZOETIS INC (ZTS) · ALNYLAM PHARMACEUTICALS INC (ALNY)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.